Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 26, 2002
The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formationSeng-Lai Tan, Semih U Tareen, Mark W Melville, et al.
Biochemistry|September 25, 2002
P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stressMichael Gale, Collin M Blakely, André Darveau, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2023
Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A reviewCollin M Blakely, Walter Weder, Lukas Bubendorf, et al.
Clinical Lung Cancer|August 1, 2024
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-AlterationsMatthew S Lara, Jonathan W Riess, Jonathan W Goldman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and TreatmentMichael P Douglas, Meera V Ragavan, Cheng Chen, et al.
Development (Cambridge, England)|February 4, 2005
Developmental stage determines the effects of MYC in the mammary epitheliumCollin M Blakely, Louis Sintasath, Celina M D'Cruz, et al.
Clinical Lung Cancer|September 21, 2021
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant ChemotherapyGavitt A Woodard, Johannes R Kratz, Greg Haro, et al.
Cancer Research|June 17, 2006
Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancyCollin M Blakely, Alexander J Stoddard, George K Belka, et al.
JTO Clinical and Research Reports|December 22, 2022
Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLCMatthew S Lara, Matthew A Gubens, Bianca Bacaltos, et al.
Scientific Reports|March 14, 2017
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolutionVanessa D Jonsson, Collin M Blakely, Luping Lin, et al.
Pageof 6